BMRA BIOMERICA INC revenue, earnings and financials
For the quarter ended August 31, 2026, BIOMERICA INC reported revenue of $1.27M (down 8.3% from a year earlier), net income of −$1.23M and diluted EPS of −$0.37; over the last four quarters revenue was $4.34M and net income −$5.01M; for the fiscal year ended May 2026 revenue was $4.45M, down 16.2% on the year before.
BMRA annual revenue and earnings
- Fiscal year ended May 2026: revenue $4.45M, gross profit $362K, operating income −$5.32M, net income −$3.78M (margin -84.8%), EPS −$1.30
- Fiscal year ended May 2025: revenue $5.31M, gross profit $498K, operating income −$5.14M, net income −$4.97M (margin -93.6%), EPS −$2.16
- Fiscal year ended May 2024: revenue $5.42M, gross profit $611K, operating income −$6.37M, net income −$5.98M (margin -110.4%), EPS −$2.84
- Fiscal year ended May 2023: revenue $5.34M, gross profit $446K, operating income −$7.22M, net income −$7.14M (margin -133.7%), EPS −$0.50
- Fiscal year ended May 2022: revenue $18.9M, gross profit $2.98M, operating income −$4.53M, net income −$4.53M (margin -24.0%), EPS −$0.36
BMRA quarterly revenue and earnings
- Quarter ended Aug 31, 2026: revenue $1.27M (down 8.3% year over year), net income −$1.23M, EPS −$0.37
- Quarter ended May 31, 2026 (from the annual report): revenue $876K (up 17.0% year over year), net income −$1.15M, EPS −$0.41
- Quarter ended Feb 28, 2026: revenue $987K (down 11.8% year over year), net income −$1.31M, EPS −$0.44
- Quarter ended Nov 30, 2025: revenue $1.21M (down 26.0% year over year), net income −$1.32M, EPS −$0.45
- Quarter ended Aug 31, 2025: revenue $1.38M (down 23.6% year over year), net income $2.00K, EPS $0.00
- Quarter ended May 31, 2025 (from the annual report): revenue $749K (down 33.0% year over year), net income −$1.54M, EPS −$0.99
- Quarter ended Feb 28, 2025: revenue $1.12M (up 10.0% year over year), net income −$1.16M, EPS −$0.48
- Quarter ended Nov 30, 2024: revenue $1.64M (up 4.4% year over year), net income −$950K, EPS −$0.06
- Quarter ended Aug 31, 2024: revenue $1.81M (up 5.5% year over year), net income −$1.32M, EPS −$0.63
- Quarter ended May 31, 2024 (from the annual report): revenue $1.12M (up 0.8% year over year), net income −$1.42M, EPS −$2.57
- Quarter ended Feb 29, 2024: revenue $1.02M (down 8.5% year over year), net income −$1.92M, EPS −$0.11
- Quarter ended Nov 30, 2023: revenue $1.57M (up 5.7% year over year), net income −$1.51M, EPS −$0.09
- Quarter ended Aug 31, 2023: revenue $1.71M (up 4.6% year over year), net income −$1.13M, EPS −$0.07
- Quarter ended May 31, 2023 (from the annual report): revenue $1.11M (down 79.1% year over year), net income −$1.79M, EPS −$0.10
- Quarter ended Feb 28, 2023: revenue $1.11M (down 85.5% year over year), net income −$1.65M, EPS −$0.12
- Quarter ended Nov 30, 2022: revenue $1.48M (down 68.1% year over year), net income −$1.63M, EPS −$0.12
- Quarter ended Aug 31, 2022: revenue $1.64M (up 29.7% year over year), net income −$2.07M, EPS −$0.16
- Quarter ended May 31, 2022 (from the annual report): revenue $5.30M, net income −$1.76M, EPS −$0.14
- Quarter ended Feb 28, 2022: revenue $7.66M (up 111.1% year over year), net income −$104K, EPS −$0.01
- Quarter ended Nov 30, 2021: revenue $4.65M, net income −$1.13M, EPS −$0.09
BMRA cash flow, buybacks and dividends
- Fiscal year ended May 2026: operating cash flow −$3.42M, share buybacks n/a
- Fiscal year ended May 2025: operating cash flow −$3.84M, share buybacks n/a
- Fiscal year ended May 2024: operating cash flow −$5.36M, share buybacks n/a
- Fiscal year ended May 2023: operating cash flow −$5.47M, share buybacks n/a
- Fiscal year ended May 2022: operating cash flow −$479K, share buybacks n/a
BMRA balance sheet
- Aug 31, 2026: cash $2.73M, total assets $8.07M, total liabilities $4.42M, shareholders' equity $3.65M
- May 31, 2026: cash $1.31M, total assets $6.76M, total liabilities $4.13M, shareholders' equity $2.63M
- Feb 28, 2026: cash $1.34M, total assets $4.88M, total liabilities $1.56M, shareholders' equity $3.32M
- Nov 30, 2025: cash $2.54M, total assets $6.03M, total liabilities $1.60M, shareholders' equity $4.44M
- Aug 31, 2025: cash $3.05M, total assets $6.85M, total liabilities $1.70M, shareholders' equity $5.16M
- May 31, 2025: cash $2.40M, total assets $5.95M, total liabilities $1.84M, shareholders' equity $4.11M
- Feb 28, 2025: cash $3.06M, total assets $7.38M, total liabilities $1.84M, shareholders' equity $5.53M
- Nov 30, 2024: cash $2.37M, total assets $7.27M, total liabilities $2.16M, shareholders' equity $5.11M
What is BMRA's revenue?
BIOMERICA INC reported $4.34M of revenue over its last four quarters, through August 31, 2026.
Is BMRA profitable?
No. BIOMERICA INC lost $5.01M over the last four quarters.
What is BMRA's EPS?
Diluted earnings per share over the last four quarters were −$1.67; −$0.37 in the latest quarter.